Angiotensin II receptor blockers (ARBs)
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for Angiotensin II receptor blockers (ARBs), covering 2011-10-03 to 2019-02-22. Get the full timeline:
Most recent: Clinical Trial Update: Effect of RAS Blockers on CKD Progression in Elderly Patients With Non Proteinuric Nephropathies (PROERCAN01) [Phase 4]